Hopefully. My one year realistic target price has risen! Now at $34. I guess that would make me a strong sell.
No position here. Who would buy at this price? Not trying to bash but like most biotech this is way overpriced by every conceivable measure.
P.S. You guys were wrong about doing an offering at $45. It would have made no difference and strengthen the company. I like this but not at $44. It's maybe at $32.
Nothing more than the Mo crowd exciting.
This sets the stage for the next leap to mid fifties and beyond.
I'd say you are missing the boat but who know with all the jesting in the congress you could get lucky but that is not a strategy.